1. Home
  2. AMPH vs NABL Comparison

AMPH vs NABL Comparison

Compare AMPH & NABL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMPH
  • NABL
  • Stock Information
  • Founded
  • AMPH 1996
  • NABL 2000
  • Country
  • AMPH United States
  • NABL United States
  • Employees
  • AMPH N/A
  • NABL N/A
  • Industry
  • AMPH Biotechnology: Pharmaceutical Preparations
  • NABL Computer Software: Prepackaged Software
  • Sector
  • AMPH Health Care
  • NABL Technology
  • Exchange
  • AMPH Nasdaq
  • NABL Nasdaq
  • Market Cap
  • AMPH 1.1B
  • NABL 1.2B
  • IPO Year
  • AMPH 2014
  • NABL N/A
  • Fundamental
  • Price
  • AMPH $23.30
  • NABL $8.08
  • Analyst Decision
  • AMPH Hold
  • NABL Buy
  • Analyst Count
  • AMPH 5
  • NABL 4
  • Target Price
  • AMPH $38.00
  • NABL $9.38
  • AVG Volume (30 Days)
  • AMPH 566.0K
  • NABL 1.2M
  • Earning Date
  • AMPH 05-07-2025
  • NABL 05-08-2025
  • Dividend Yield
  • AMPH N/A
  • NABL N/A
  • EPS Growth
  • AMPH N/A
  • NABL N/A
  • EPS
  • AMPH 2.77
  • NABL 0.08
  • Revenue
  • AMPH $730,659,000.00
  • NABL $470,595,000.00
  • Revenue This Year
  • AMPH $1.48
  • NABL $7.38
  • Revenue Next Year
  • AMPH $5.97
  • NABL $9.67
  • P/E Ratio
  • AMPH $8.47
  • NABL $101.88
  • Revenue Growth
  • AMPH 8.05
  • NABL 7.98
  • 52 Week Low
  • AMPH $22.64
  • NABL $6.07
  • 52 Week High
  • AMPH $53.96
  • NABL $15.49
  • Technical
  • Relative Strength Index (RSI)
  • AMPH 39.25
  • NABL 67.94
  • Support Level
  • AMPH $23.30
  • NABL $7.07
  • Resistance Level
  • AMPH $25.36
  • NABL $8.29
  • Average True Range (ATR)
  • AMPH 0.86
  • NABL 0.24
  • MACD
  • AMPH 0.10
  • NABL 0.17
  • Stochastic Oscillator
  • AMPH 1.66
  • NABL 87.69

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

About NABL N-able Inc.

N-able Inc is a provider of cloud-based software solutions for managed service providers (MSPs), enabling them to support digital transformation and growth for small and medium-sized enterprises. With a flexible technology platform and powerful integrations, N-able makes it easy for MSPs to monitor, manage, and protect their end-customer systems, data, and networks. The company's growing portfolio of management, security, automation, and data protection solutions is built for IT services management professionals. Geographically, the majority of revenue is from the United States. The company also has a presence in the United Kingdom and all other International regions.

Share on Social Networks: